

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * COPI coating of Golgi vesicle (GO:0048205) | 9.36420723 |
| 2 | * Golgi transport vesicle coating (GO:0048200) | 9.36420723 |
| 3 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 6.78494994 |
| 4 | COPII vesicle coating (GO:0048208) | 6.36638594 |
| 5 | protein retention in ER lumen (GO:0006621) | 5.88814969 |
| 6 | signal peptide processing (GO:0006465) | 5.35041882 |
| 7 | * retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 4.90553435 |
| 8 | nuclear pore complex assembly (GO:0051292) | 4.83297818 |
| 9 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 4.52597641 |
| 10 | positive regulation of nuclease activity (GO:0032075) | 4.34247630 |
| 11 | nuclear pore organization (GO:0006999) | 4.33573524 |
| 12 | endoplasmic reticulum unfolded protein response (GO:0030968) | 4.13775591 |
| 13 | * vesicle coating (GO:0006901) | 4.11264561 |
| 14 | cellular response to unfolded protein (GO:0034620) | 4.04588296 |
| 15 | regulation of nuclease activity (GO:0032069) | 4.03381004 |
| 16 | exocrine pancreas development (GO:0031017) | 4.01619172 |
| 17 | sequestering of metal ion (GO:0051238) | 4.00459536 |
| 18 | ribosome assembly (GO:0042255) | 3.99623956 |
| 19 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 3.95077423 |
| 20 | ER overload response (GO:0006983) | 3.89255969 |
| 21 | ER-nucleus signaling pathway (GO:0006984) | 3.88989760 |
| 22 | mitotic sister chromatid cohesion (GO:0007064) | 3.87851809 |
| 23 | cell adhesion mediated by integrin (GO:0033627) | 3.83445464 |
| 24 | cellular response to topologically incorrect protein (GO:0035967) | 3.83026044 |
| 25 | endocrine pancreas development (GO:0031018) | 3.69904332 |
| 26 | cellular response to vitamin D (GO:0071305) | 3.60826670 |
| 27 | peptide catabolic process (GO:0043171) | 3.60256485 |
| 28 | protein maturation by protein folding (GO:0022417) | 3.57263557 |
| 29 | 4-hydroxyproline metabolic process (GO:0019471) | 3.41464507 |
| 30 | non-recombinational repair (GO:0000726) | 3.41056711 |
| 31 | double-strand break repair via nonhomologous end joining (GO:0006303) | 3.41056711 |
| 32 | pore complex assembly (GO:0046931) | 3.40881070 |
| 33 | mitotic metaphase plate congression (GO:0007080) | 3.40177585 |
| 34 | mitotic sister chromatid segregation (GO:0000070) | 3.37926023 |
| 35 | metaphase plate congression (GO:0051310) | 3.37548432 |
| 36 | sister chromatid segregation (GO:0000819) | 3.37215539 |
| 37 | response to endoplasmic reticulum stress (GO:0034976) | 3.34008470 |
| 38 | keratan sulfate catabolic process (GO:0042340) | 3.31439077 |
| 39 | proteasome assembly (GO:0043248) | 3.30799108 |
| 40 | ER to Golgi vesicle-mediated transport (GO:0006888) | 3.30074187 |
| 41 | regulation of low-density lipoprotein particle receptor biosynthetic process (GO:0045714) | 3.23548101 |
| 42 | establishment of chromosome localization (GO:0051303) | 3.21498607 |
| 43 | type B pancreatic cell development (GO:0003323) | 3.20173949 |
| 44 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 3.19535341 |
| 45 | peptide hormone processing (GO:0016486) | 3.18863023 |
| 46 | protein carboxylation (GO:0018214) | 3.17087586 |
| 47 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.17087586 |
| 48 | tRNA aminoacylation for protein translation (GO:0006418) | 3.12547154 |
| 49 | protein N-linked glycosylation via asparagine (GO:0018279) | 3.11616405 |
| 50 | intestinal cholesterol absorption (GO:0030299) | 3.09489582 |
| 51 | peptidyl-asparagine modification (GO:0018196) | 3.08440309 |
| 52 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 3.07989771 |
| 53 | response to unfolded protein (GO:0006986) | 3.07627788 |
| 54 | tRNA aminoacylation (GO:0043039) | 3.06758662 |
| 55 | amino acid activation (GO:0043038) | 3.06758662 |
| 56 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 2.99709843 |
| 57 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.97620207 |
| 58 | regulation of mitotic spindle organization (GO:0060236) | 2.97598279 |
| 59 | intestinal absorption (GO:0050892) | 2.97197983 |
| 60 | response to topologically incorrect protein (GO:0035966) | 2.96486219 |
| 61 | regulation of centriole replication (GO:0046599) | 2.94515556 |
| 62 | positive regulation of protein autophosphorylation (GO:0031954) | 2.93491619 |
| 63 | collagen fibril organization (GO:0030199) | 2.90098737 |
| 64 | cellular response to vitamin (GO:0071295) | 2.89666859 |
| 65 | regulation of hexokinase activity (GO:1903299) | 2.85523782 |
| 66 | regulation of glucokinase activity (GO:0033131) | 2.85523782 |
| 67 | valine metabolic process (GO:0006573) | 2.83591427 |
| 68 | protein localization to kinetochore (GO:0034501) | 2.83418473 |
| 69 | protein N-linked glycosylation (GO:0006487) | 2.82241476 |
| 70 | spindle checkpoint (GO:0031577) | 2.81744405 |
| 71 | ventricular cardiac muscle cell development (GO:0055015) | 2.80859115 |
| 72 | hormone catabolic process (GO:0042447) | 2.78057605 |
| 73 | response to X-ray (GO:0010165) | 2.77950569 |
| 74 | regulation of DNA endoreduplication (GO:0032875) | 2.76386666 |
| 75 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.72675555 |
| 76 | L-phenylalanine catabolic process (GO:0006559) | 2.72675555 |
| 77 | mitotic nuclear envelope disassembly (GO:0007077) | 2.72367867 |
| 78 | regulation of transforming growth factor beta2 production (GO:0032909) | 2.71803609 |
| 79 | glandular epithelial cell development (GO:0002068) | 2.70606370 |
| 80 | cullin deneddylation (GO:0010388) | 2.70444801 |
| 81 | sequestering of extracellular ligand from receptor (GO:0035581) | 2.69585564 |
| 82 | regulation of sister chromatid cohesion (GO:0007063) | 2.68329856 |
| 83 | attachment of spindle microtubules to kinetochore (GO:0008608) | 2.66417137 |
| 84 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 2.65141323 |
| 85 | mitotic spindle checkpoint (GO:0071174) | 2.63891880 |
| 86 | zinc ion transport (GO:0006829) | 2.62998022 |
| 87 | protein localization to chromosome, centromeric region (GO:0071459) | 2.62476456 |
| 88 | keratinocyte development (GO:0003334) | 2.59954558 |
| 89 | positive regulation of glycolytic process (GO:0045821) | 2.59745973 |
| 90 | establishment of integrated proviral latency (GO:0075713) | 2.58905642 |
| 91 | nuclear envelope disassembly (GO:0051081) | 2.58714467 |
| 92 | membrane disassembly (GO:0030397) | 2.58714467 |
| 93 | protein heterotetramerization (GO:0051290) | 2.57921288 |
| 94 | glandular epithelial cell differentiation (GO:0002067) | 2.57822618 |
| 95 | regulation of ER to Golgi vesicle-mediated transport (GO:0060628) | 2.57489375 |
| 96 | positive regulation of hormone biosynthetic process (GO:0046886) | 2.55808766 |
| 97 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 2.55278612 |
| 98 | Golgi organization (GO:0007030) | 2.54106895 |
| 99 | DNA ligation (GO:0006266) | 2.53645101 |
| 100 | lactate metabolic process (GO:0006089) | 2.50652824 |
| 101 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.50608745 |
| 102 | spindle assembly involved in mitosis (GO:0090307) | 2.49642182 |
| 103 | regulation of chromosome segregation (GO:0051983) | 2.49612791 |
| 104 | female gonad development (GO:0008585) | 2.49051149 |
| 105 | meiotic chromosome segregation (GO:0045132) | 2.48871730 |
| 106 | growth hormone receptor signaling pathway (GO:0060396) | 2.48430617 |
| 107 | membrane budding (GO:0006900) | 2.47718484 |
| 108 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 2.47559445 |
| 109 | regulation of metalloenzyme activity (GO:0048552) | 2.45972550 |
| 110 | protein autoprocessing (GO:0016540) | 2.45613390 |
| 111 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.45310320 |
| 112 | DNA double-strand break processing (GO:0000729) | 2.44705054 |
| 113 | mitotic spindle organization (GO:0007052) | 2.44313882 |
| 114 | cellular zinc ion homeostasis (GO:0006882) | 2.43837825 |
| 115 | CENP-A containing nucleosome assembly (GO:0034080) | 2.43116368 |
| 116 | tricarboxylic acid cycle (GO:0006099) | 2.43050714 |
| 117 | nucleotide transmembrane transport (GO:1901679) | 2.42762819 |
| 118 | nucleotide-sugar biosynthetic process (GO:0009226) | 2.42462819 |
| 119 | regulation of mitotic metaphase/anaphase transition (GO:0030071) | 2.41637882 |
| 120 | regulation of metaphase/anaphase transition of cell cycle (GO:1902099) | 2.41637882 |
| 121 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.39785247 |
| 122 | kinetochore organization (GO:0051383) | 2.39447040 |
| 123 | protein deneddylation (GO:0000338) | 2.38827923 |
| 124 | embryonic foregut morphogenesis (GO:0048617) | 2.38248151 |
| 125 | regulation of spindle organization (GO:0090224) | 2.38199908 |
| 126 | regulation of cofactor metabolic process (GO:0051193) | 2.38061707 |
| 127 | regulation of coenzyme metabolic process (GO:0051196) | 2.38061707 |
| 128 | positive regulation of mitotic metaphase/anaphase transition (GO:0045842) | 2.37243334 |
| 129 | positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101) | 2.37243334 |
| 130 | positive regulation of mitotic sister chromatid separation (GO:1901970) | 2.37243334 |
| 131 | wound healing, spreading of epidermal cells (GO:0035313) | 2.37057743 |
| 132 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 2.36765873 |
| 133 | sister chromatid cohesion (GO:0007062) | 2.36085299 |
| 134 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.35013521 |
| 135 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.35013521 |
| 136 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.34483196 |
| 137 | positive regulation of glycoprotein metabolic process (GO:1903020) | 2.34115949 |
| 138 | lipoprotein metabolic process (GO:0042157) | 2.32940722 |
| 139 | negative regulation of chondrocyte differentiation (GO:0032331) | 2.32929917 |
| 140 | spindle assembly checkpoint (GO:0071173) | 2.32576440 |
| 141 | regulation of sulfur metabolic process (GO:0042762) | 2.32183256 |
| 142 | negative regulation of keratinocyte proliferation (GO:0010839) | 2.31342314 |
| 143 | anterior/posterior axis specification, embryo (GO:0008595) | 2.31279591 |
| 144 | branched-chain amino acid catabolic process (GO:0009083) | 2.30275685 |
| 145 | microtubule cytoskeleton organization involved in mitosis (GO:1902850) | 2.30137589 |
| 146 | chondrocyte development (GO:0002063) | 2.29952079 |
| 147 | mitotic spindle assembly checkpoint (GO:0007094) | 2.29656700 |
| 148 | columnar/cuboidal epithelial cell development (GO:0002066) | 2.29241136 |
| 149 | resolution of meiotic recombination intermediates (GO:0000712) | 2.29197442 |
| 150 | lipid particle organization (GO:0034389) | 2.29094113 |
| 151 | alpha-linolenic acid metabolic process (GO:0036109) | 2.29067395 |
| 152 | lung vasculature development (GO:0060426) | 2.28972721 |
| 153 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.27485378 |
| 154 | L-phenylalanine metabolic process (GO:0006558) | 2.27485378 |
| 155 | transcytosis (GO:0045056) | 2.27285328 |
| 156 | apoptotic cell clearance (GO:0043277) | 2.26872629 |
| 157 | regulation of translation in response to stress (GO:0043555) | 2.25903766 |
| 158 | regulation of mitotic sister chromatid segregation (GO:0033047) | 2.25424448 |
| 159 | zinc ion homeostasis (GO:0055069) | 2.24834179 |
| 160 | positive regulation of receptor biosynthetic process (GO:0010870) | 2.24574797 |
| 161 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.24243459 |
| 162 | tetrahydrofolate metabolic process (GO:0046653) | 2.22725404 |
| 163 | cellular response to hepatocyte growth factor stimulus (GO:0035729) | 2.21710594 |
| 164 | response to hepatocyte growth factor (GO:0035728) | 2.21710594 |
| 165 | regulation of cholesterol homeostasis (GO:2000188) | 2.21674692 |
| 166 | reverse cholesterol transport (GO:0043691) | 2.19635161 |
| 167 | homocysteine metabolic process (GO:0050667) | 2.18933648 |
| 168 | skin morphogenesis (GO:0043589) | 2.17587033 |
| 169 | sulfur amino acid catabolic process (GO:0000098) | 2.16368483 |
| 170 | negative regulation of fatty acid transport (GO:2000192) | 2.16085099 |
| 171 | negative regulation of fibrinolysis (GO:0051918) | 2.15560054 |
| 172 | tricarboxylic acid metabolic process (GO:0072350) | 2.15228352 |
| 173 | cellular response to growth hormone stimulus (GO:0071378) | 2.14557453 |
| 174 | cellular response to nutrient (GO:0031670) | 2.13320337 |
| 175 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 2.11636346 |
| 176 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 2.11636346 |
| 177 | aromatic amino acid family catabolic process (GO:0009074) | 2.10278645 |
| 178 | regulation of extracellular matrix disassembly (GO:0010715) | 2.10228370 |
| 179 | regulation of receptor biosynthetic process (GO:0010869) | 2.10179415 |
| 180 | gland morphogenesis (GO:0022612) | 2.10082626 |
| 181 | negative regulation of glycogen biosynthetic process (GO:0045719) | 2.09735114 |
| 182 | high-density lipoprotein particle remodeling (GO:0034375) | 2.09671697 |
| 183 | maintenance of protein localization in organelle (GO:0072595) | 2.09339269 |
| 184 | tyrosine metabolic process (GO:0006570) | 2.07672187 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | GATA1_22025678_ChIP-Seq_K562_Human | 4.25316913 |
| 2 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.86085215 |
| 3 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.79679552 |
| 4 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 3.45566412 |
| 5 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 3.34544866 |
| 6 | CLOCK_20551151_ChIP-Seq_293T_Human | 3.32326661 |
| 7 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.05203403 |
| 8 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.01730864 |
| 9 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.99136398 |
| 10 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.87847590 |
| 11 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.77819317 |
| 12 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.72273427 |
| 13 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.63935223 |
| 14 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.45358054 |
| 15 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.30682064 |
| 16 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.28797581 |
| 17 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.18205086 |
| 18 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 2.14693206 |
| 19 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.14535314 |
| 20 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.12143639 |
| 21 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 2.10279938 |
| 22 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.08962510 |
| 23 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.07749066 |
| 24 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.06203157 |
| 25 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.98152167 |
| 26 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.96947083 |
| 27 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.93657629 |
| 28 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.87764184 |
| 29 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.86989888 |
| 30 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.82681090 |
| 31 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.82272336 |
| 32 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.81060168 |
| 33 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.78262489 |
| 34 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.76504861 |
| 35 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.76134647 |
| 36 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.71980603 |
| 37 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.67660005 |
| 38 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.67537444 |
| 39 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.66334622 |
| 40 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.64692394 |
| 41 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.63884709 |
| 42 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.63389184 |
| 43 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.58126217 |
| 44 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.57661695 |
| 45 | * FUS_26573619_Chip-Seq_HEK293_Human | 1.57122074 |
| 46 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.56816602 |
| 47 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.55822039 |
| 48 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.55403238 |
| 49 | EWS_26573619_Chip-Seq_HEK293_Human | 1.54621515 |
| 50 | * KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.51185066 |
| 51 | * VDR_23849224_ChIP-Seq_CD4+_Human | 1.48042121 |
| 52 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.47849456 |
| 53 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.47267475 |
| 54 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.46714894 |
| 55 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.44841388 |
| 56 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.44534416 |
| 57 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.43347007 |
| 58 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.43227226 |
| 59 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.42849579 |
| 60 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.40918844 |
| 61 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.39774390 |
| 62 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.38499072 |
| 63 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.38140248 |
| 64 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.37981690 |
| 65 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.37981690 |
| 66 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.36580368 |
| 67 | CJUN_26792858_Chip-Seq_BT549_Human | 1.34433382 |
| 68 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.33868450 |
| 69 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.33559632 |
| 70 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.33559632 |
| 71 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.33530948 |
| 72 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.33211699 |
| 73 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.29966316 |
| 74 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.28260080 |
| 75 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.28099945 |
| 76 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.26935030 |
| 77 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.26213899 |
| 78 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.25063758 |
| 79 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.24973731 |
| 80 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.24818282 |
| 81 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.24335008 |
| 82 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.24238932 |
| 83 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.21413998 |
| 84 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.20351591 |
| 85 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.20126124 |
| 86 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.19660314 |
| 87 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.18803196 |
| 88 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.18625766 |
| 89 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.17723856 |
| 90 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.17414997 |
| 91 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.17232464 |
| 92 | CHD1_26751641_Chip-Seq_LNCaP_Human | 1.17192311 |
| 93 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.16539459 |
| 94 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.15317352 |
| 95 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.14987644 |
| 96 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.14911864 |
| 97 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.13328517 |
| 98 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.11704811 |
| 99 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.11295257 |
| 100 | * FOXP3_21729870_ChIP-Seq_TREG_Human | 1.10799626 |
| 101 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.10446728 |
| 102 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.09747709 |
| 103 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.08948940 |
| 104 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.08761431 |
| 105 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.08519886 |
| 106 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.08039330 |
| 107 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.07396343 |
| 108 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.06980226 |
| 109 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.06946059 |
| 110 | P300_19829295_ChIP-Seq_ESCs_Human | 1.06858972 |
| 111 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.06487151 |
| 112 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.04714165 |
| 113 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.04575557 |
| 114 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.02462248 |
| 115 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.02013514 |
| 116 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 1.01004870 |
| 117 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.00827980 |
| 118 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.00647451 |
| 119 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.00555944 |
| 120 | ELF5_23300383_ChIP-Seq_T47D_Human | 1.00321971 |
| 121 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.00102062 |
| 122 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.99942204 |
| 123 | * CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.98916919 |
| 124 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.98645934 |
| 125 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.98202784 |
| 126 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.98123655 |
| 127 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 0.97305950 |
| 128 | * FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.96305520 |
| 129 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.95840508 |
| 130 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.95067560 |
| 131 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 0.95059874 |
| 132 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.94922753 |
| 133 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 0.94789757 |
| 134 | E2F7_22180533_ChIP-Seq_HELA_Human | 0.94714899 |
| 135 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.93226298 |
| 136 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.93158078 |
| 137 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.92971014 |
| 138 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 0.92760039 |
| 139 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.92187754 |
| 140 | EOMES_21245162_ChIP-Seq_HESCs_Human | 0.91937395 |
| 141 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.91808762 |
| 142 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.91725358 |
| 143 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.91407796 |
| 144 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.91345439 |
| 145 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.90953906 |
| 146 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.90790354 |
| 147 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 0.90284590 |
| 148 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.90069650 |
| 149 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.89426889 |
| 150 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.89104232 |
| 151 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.88610720 |
| 152 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.87703415 |
| 153 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.87637616 |
| 154 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.87551710 |
| 155 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.87324794 |
| 156 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.85648665 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008438_abnormal_cutaneous_collagen | 3.66575621 |
| 2 | MP0002877_abnormal_melanocyte_morpholog | 3.46007662 |
| 3 | MP0002139_abnormal_hepatobiliary_system | 2.92203455 |
| 4 | MP0003950_abnormal_plasma_membrane | 2.92123759 |
| 5 | MP0006054_spinal_hemorrhage | 2.78745481 |
| 6 | MP0003705_abnormal_hypodermis_morpholog | 2.56879184 |
| 7 | MP0003941_abnormal_skin_development | 2.48381181 |
| 8 | MP0004957_abnormal_blastocyst_morpholog | 2.39124069 |
| 9 | MP0005365_abnormal_bile_salt | 2.39004104 |
| 10 | MP0010094_abnormal_chromosome_stability | 2.29968493 |
| 11 | MP0005503_abnormal_tendon_morphology | 2.25057656 |
| 12 | MP0003195_calcinosis | 2.22176748 |
| 13 | MP0005275_abnormal_skin_tensile | 2.11811505 |
| 14 | MP0008057_abnormal_DNA_replication | 2.09397142 |
| 15 | MP0005360_urolithiasis | 2.05180048 |
| 16 | MP0005220_abnormal_exocrine_pancreas | 2.03559557 |
| 17 | MP0003252_abnormal_bile_duct | 1.97913365 |
| 18 | MP0009780_abnormal_chondrocyte_physiolo | 1.96045540 |
| 19 | MP0004264_abnormal_extraembryonic_tissu | 1.86844928 |
| 20 | MP0003300_gastrointestinal_ulcer | 1.85864610 |
| 21 | MP0005085_abnormal_gallbladder_physiolo | 1.84183672 |
| 22 | MP0003806_abnormal_nucleotide_metabolis | 1.73737167 |
| 23 | MP0003693_abnormal_embryo_hatching | 1.73602013 |
| 24 | MP0003283_abnormal_digestive_organ | 1.73196930 |
| 25 | MP0004272_abnormal_basement_membrane | 1.72813666 |
| 26 | MP0010352_gastrointestinal_tract_polyps | 1.70251746 |
| 27 | MP0002138_abnormal_hepatobiliary_system | 1.69138839 |
| 28 | MP0002693_abnormal_pancreas_physiology | 1.67210051 |
| 29 | MP0008058_abnormal_DNA_repair | 1.65489563 |
| 30 | MP0001944_abnormal_pancreas_morphology | 1.65363529 |
| 31 | MP0002896_abnormal_bone_mineralization | 1.62259743 |
| 32 | MP0003077_abnormal_cell_cycle | 1.60306550 |
| 33 | MP0002102_abnormal_ear_morphology | 1.55922056 |
| 34 | MP0010234_abnormal_vibrissa_follicle | 1.55159341 |
| 35 | MP0003890_abnormal_embryonic-extraembry | 1.54639702 |
| 36 | MP0008932_abnormal_embryonic_tissue | 1.54489500 |
| 37 | MP0000013_abnormal_adipose_tissue | 1.52689922 |
| 38 | MP0005408_hypopigmentation | 1.51719184 |
| 39 | MP0000372_irregular_coat_pigmentation | 1.50843229 |
| 40 | MP0003566_abnormal_cell_adhesion | 1.49336645 |
| 41 | MP0009384_cardiac_valve_regurgitation | 1.48547636 |
| 42 | MP0001666_abnormal_nutrient_absorption | 1.47725746 |
| 43 | MP0003111_abnormal_nucleus_morphology | 1.46139659 |
| 44 | MP0003183_abnormal_peptide_metabolism | 1.39750434 |
| 45 | MP0010386_abnormal_urinary_bladder | 1.37373259 |
| 46 | MP0003718_maternal_effect | 1.34716788 |
| 47 | MP0009053_abnormal_anal_canal | 1.34595828 |
| 48 | MP0002060_abnormal_skin_morphology | 1.33185701 |
| 49 | MP0000678_abnormal_parathyroid_gland | 1.30951799 |
| 50 | MP0002084_abnormal_developmental_patter | 1.30563119 |
| 51 | MP0000647_abnormal_sebaceous_gland | 1.29899067 |
| 52 | MP0001697_abnormal_embryo_size | 1.27963885 |
| 53 | MP0005023_abnormal_wound_healing | 1.26547916 |
| 54 | MP0003385_abnormal_body_wall | 1.26079339 |
| 55 | MP0010678_abnormal_skin_adnexa | 1.25621290 |
| 56 | MP0000516_abnormal_urinary_system | 1.25425494 |
| 57 | MP0005367_renal/urinary_system_phenotyp | 1.25425494 |
| 58 | MP0001672_abnormal_embryogenesis/_devel | 1.24937888 |
| 59 | MP0005380_embryogenesis_phenotype | 1.24937888 |
| 60 | MP0005076_abnormal_cell_differentiation | 1.24705490 |
| 61 | MP0010030_abnormal_orbit_morphology | 1.23390523 |
| 62 | MP0003984_embryonic_growth_retardation | 1.22266703 |
| 63 | MP0002088_abnormal_embryonic_growth/wei | 1.19460416 |
| 64 | MP0009643_abnormal_urine_homeostasis | 1.18628340 |
| 65 | MP0001915_intracranial_hemorrhage | 1.18234474 |
| 66 | MP0001243_abnormal_dermal_layer | 1.14352299 |
| 67 | MP0005623_abnormal_meninges_morphology | 1.13055803 |
| 68 | MP0003786_premature_aging | 1.13053827 |
| 69 | MP0001730_embryonic_growth_arrest | 1.11282809 |
| 70 | MP0000163_abnormal_cartilage_morphology | 1.10329337 |
| 71 | MP0000569_abnormal_digit_pigmentation | 1.09033310 |
| 72 | MP0002090_abnormal_vision | 1.08727510 |
| 73 | MP0005508_abnormal_skeleton_morphology | 1.08599224 |
| 74 | MP0002295_abnormal_pulmonary_circulatio | 1.08063363 |
| 75 | MP0002933_joint_inflammation | 1.07906009 |
| 76 | MP0002086_abnormal_extraembryonic_tissu | 1.07373381 |
| 77 | MP0003279_aneurysm | 1.07162873 |
| 78 | MP0003795_abnormal_bone_structure | 1.05829517 |
| 79 | MP0005395_other_phenotype | 1.03462076 |
| 80 | MP0008877_abnormal_DNA_methylation | 1.03265724 |
| 81 | MP0003123_paternal_imprinting | 1.02934345 |
| 82 | MP0008875_abnormal_xenobiotic_pharmacok | 1.01490541 |
| 83 | MP0005187_abnormal_penis_morphology | 1.01394318 |
| 84 | MP0004043_abnormal_pH_regulation | 1.00760892 |
| 85 | MP0002115_abnormal_skeleton_extremities | 1.00251551 |
| 86 | MP0000427_abnormal_hair_cycle | 0.98653833 |
| 87 | MP0002928_abnormal_bile_duct | 0.98062904 |
| 88 | MP0003937_abnormal_limbs/digits/tail_de | 0.98031994 |
| 89 | MP0004782_abnormal_surfactant_physiolog | 0.97588180 |
| 90 | MP0001533_abnormal_skeleton_physiology | 0.97387050 |
| 91 | MP0001542_abnormal_bone_strength | 0.97068271 |
| 92 | MP0009697_abnormal_copulation | 0.96293376 |
| 93 | MP0010329_abnormal_lipoprotein_level | 0.96020249 |
| 94 | MP0000358_abnormal_cell_content/ | 0.95493661 |
| 95 | MP0000609_abnormal_liver_physiology | 0.95364240 |
| 96 | MP0002006_tumorigenesis | 0.94234742 |
| 97 | MP0003755_abnormal_palate_morphology | 0.93796106 |
| 98 | MP0010368_abnormal_lymphatic_system | 0.93754038 |
| 99 | MP0002233_abnormal_nose_morphology | 0.93579262 |
| 100 | MP0000350_abnormal_cell_proliferation | 0.93412961 |
| 101 | MP0003221_abnormal_cardiomyocyte_apopto | 0.92625252 |
| 102 | MP0003186_abnormal_redox_activity | 0.91016829 |
| 103 | MP0005257_abnormal_intraocular_pressure | 0.90989219 |
| 104 | MP0005379_endocrine/exocrine_gland_phen | 0.90869680 |
| 105 | MP0003868_abnormal_feces_composition | 0.90658833 |
| 106 | MP0002080_prenatal_lethality | 0.90652338 |
| 107 | MP0005390_skeleton_phenotype | 0.89787751 |
| 108 | MP0002085_abnormal_embryonic_tissue | 0.89438105 |
| 109 | MP0002166_altered_tumor_susceptibility | 0.89401091 |
| 110 | MP0002078_abnormal_glucose_homeostasis | 0.88586257 |
| 111 | MP0005171_absent_coat_pigmentation | 0.88220712 |
| 112 | MP0000003_abnormal_adipose_tissue | 0.86874686 |
| 113 | MP0001756_abnormal_urination | 0.86321435 |
| 114 | MP0002938_white_spotting | 0.85575563 |
| 115 | MP0005058_abnormal_lysosome_morphology | 0.85328728 |
| 116 | MP0005248_abnormal_Harderian_gland | 0.85276495 |
| 117 | MP0003315_abnormal_perineum_morphology | 0.85216926 |
| 118 | MP0009840_abnormal_foam_cell | 0.84729368 |
| 119 | MP0005083_abnormal_biliary_tract | 0.83982829 |
| 120 | MP0002168_other_aberrant_phenotype | 0.83632235 |
| 121 | MP0005197_abnormal_uvea_morphology | 0.83272664 |
| 122 | MP0003091_abnormal_cell_migration | 0.82714337 |
| 123 | MP0002254_reproductive_system_inflammat | 0.82566398 |
| 124 | MP0000598_abnormal_liver_morphology | 0.82425287 |
| 125 | MP0010307_abnormal_tumor_latency | 0.82331015 |
| 126 | MP0000613_abnormal_salivary_gland | 0.82296999 |
| 127 | MP0006072_abnormal_retinal_apoptosis | 0.82018101 |
| 128 | MP0002113_abnormal_skeleton_development | 0.81391092 |
| 129 | MP0009703_decreased_birth_body | 0.78928990 |
| 130 | MP0002998_abnormal_bone_remodeling | 0.78843102 |
| 131 | MP0005084_abnormal_gallbladder_morpholo | 0.77563944 |
| 132 | MP0002177_abnormal_outer_ear | 0.77193351 |
| 133 | MP0001216_abnormal_epidermal_layer | 0.75215145 |
| 134 | MP0005384_cellular_phenotype | 0.74642684 |
| 135 | MP0008007_abnormal_cellular_replicative | 0.74455820 |
| 136 | MP0004134_abnormal_chest_morphology | 0.74116996 |
| 137 | MP0005621_abnormal_cell_physiology | 0.73970882 |
| 138 | MP0004197_abnormal_fetal_growth/weight/ | 0.73888622 |
| 139 | MP0003935_abnormal_craniofacial_develop | 0.73516023 |
| 140 | MP0002009_preneoplasia | 0.73445436 |
| 141 | MP0001879_abnormal_lymphatic_vessel | 0.72703451 |
| 142 | MP0005332_abnormal_amino_acid | 0.72693106 |
| 143 | MP0004233_abnormal_muscle_weight | 0.72100077 |
| 144 | MP0003191_abnormal_cellular_cholesterol | 0.72078078 |
| 145 | MP0003436_decreased_susceptibility_to | 0.71271951 |
| 146 | MP0000371_diluted_coat_color | 0.70000253 |
| 147 | MP0001191_abnormal_skin_condition | 0.69767649 |
| 148 | MP0000538_abnormal_urinary_bladder | 0.69612067 |
| 149 | MP0005319_abnormal_enzyme/_coenzyme | 0.69486376 |
| 150 | MP0000537_abnormal_urethra_morphology | 0.69007290 |
| 151 | MP0002909_abnormal_adrenal_gland | 0.68605214 |
| 152 | MP0000767_abnormal_smooth_muscle | 0.68509902 |
| 153 | MP0001849_ear_inflammation | 0.68250569 |
| 154 | MP0001881_abnormal_mammary_gland | 0.68200578 |
| 155 | MP0001299_abnormal_eye_distance/ | 0.66607360 |
| 156 | MP0003942_abnormal_urinary_system | 0.65565206 |
| 157 | MP0003959_abnormal_lean_body | 0.65063830 |
| 158 | MP0003943_abnormal_hepatobiliary_system | 0.64906409 |
| 159 | MP0002118_abnormal_lipid_homeostasis | 0.63759599 |
| 160 | MP0004019_abnormal_vitamin_homeostasis | 0.62933116 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hypoglycemic coma (HP:0001325) | 4.42607005 |
| 2 | Hypoglycemic seizures (HP:0002173) | 4.16527446 |
| 3 | Cervical subluxation (HP:0003308) | 3.84691664 |
| 4 | Hyperinsulinemic hypoglycemia (HP:0000825) | 3.73897391 |
| 5 | Symptomatic seizures (HP:0011145) | 3.68671337 |
| 6 | Abnormality of the intrinsic pathway (HP:0010989) | 3.46175932 |
| 7 | Hyperglycemia (HP:0003074) | 3.25073597 |
| 8 | Pancreatic islet-cell hyperplasia (HP:0004510) | 3.24086598 |
| 9 | Abnormal foot bone ossification (HP:0010675) | 3.07841857 |
| 10 | Abnormality of the common coagulation pathway (HP:0010990) | 3.07327918 |
| 11 | Abnormality of the pancreatic islet cells (HP:0006476) | 3.07287633 |
| 12 | Abnormality of endocrine pancreas physiology (HP:0012093) | 3.07287633 |
| 13 | Epiphyseal dysplasia (HP:0002656) | 3.06088872 |
| 14 | Abnormality of glycolysis (HP:0004366) | 3.02871653 |
| 15 | Protrusio acetabuli (HP:0003179) | 2.99515895 |
| 16 | Increased serum pyruvate (HP:0003542) | 2.98909224 |
| 17 | Abnormal pancreas size (HP:0012094) | 2.82729419 |
| 18 | Metaphyseal cupping (HP:0003021) | 2.78072316 |
| 19 | Premature rupture of membranes (HP:0001788) | 2.77467814 |
| 20 | Follicular hyperkeratosis (HP:0007502) | 2.64551509 |
| 21 | Intrahepatic cholestasis (HP:0001406) | 2.60202529 |
| 22 | Volvulus (HP:0002580) | 2.55798169 |
| 23 | Arterial tortuosity (HP:0005116) | 2.54023467 |
| 24 | Vascular tortuosity (HP:0004948) | 2.53872781 |
| 25 | Abnormal tarsal ossification (HP:0008369) | 2.53348139 |
| 26 | Overlapping toe (HP:0001845) | 2.53208166 |
| 27 | Hypolipoproteinemia (HP:0010981) | 2.50892971 |
| 28 | Generalized aminoaciduria (HP:0002909) | 2.48498147 |
| 29 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.45884348 |
| 30 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.44367552 |
| 31 | Mucopolysacchariduria (HP:0008155) | 2.44367552 |
| 32 | Thoracolumbar scoliosis (HP:0002944) | 2.43454303 |
| 33 | Protuberant abdomen (HP:0001538) | 2.42516620 |
| 34 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.42216112 |
| 35 | Thyroid carcinoma (HP:0002890) | 2.38915716 |
| 36 | Ketoacidosis (HP:0001993) | 2.38433666 |
| 37 | Shoulder girdle muscle weakness (HP:0003547) | 2.37382378 |
| 38 | Abnormal umbilical cord blood vessels (HP:0011403) | 2.35205293 |
| 39 | Single umbilical artery (HP:0001195) | 2.35205293 |
| 40 | Abnormality of the fetal cardiovascular system (HP:0010948) | 2.35205293 |
| 41 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.32012117 |
| 42 | Microglossia (HP:0000171) | 2.30721899 |
| 43 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.30705490 |
| 44 | Abnormality of chromosome stability (HP:0003220) | 2.30110119 |
| 45 | Abnormality of methionine metabolism (HP:0010901) | 2.28226001 |
| 46 | Beaking of vertebral bodies (HP:0004568) | 2.25514321 |
| 47 | Tetraparesis (HP:0002273) | 2.25309410 |
| 48 | Platyspondyly (HP:0000926) | 2.23565960 |
| 49 | Delayed epiphyseal ossification (HP:0002663) | 2.23004561 |
| 50 | Cupped ribs (HP:0000887) | 2.21098379 |
| 51 | Abnormality of the hip-girdle musculature (HP:0001445) | 2.21081645 |
| 52 | Abnormality of the musculature of the pelvis (HP:0001469) | 2.21081645 |
| 53 | Aortic dissection (HP:0002647) | 2.19611255 |
| 54 | Hepatoblastoma (HP:0002884) | 2.18170693 |
| 55 | Aortic aneurysm (HP:0004942) | 2.18069396 |
| 56 | Chromsome breakage (HP:0040012) | 2.17102093 |
| 57 | Conjugated hyperbilirubinemia (HP:0002908) | 2.14455315 |
| 58 | Vitreoretinal degeneration (HP:0000655) | 2.13624992 |
| 59 | Deep philtrum (HP:0002002) | 2.13008648 |
| 60 | Abdominal distention (HP:0003270) | 2.07513656 |
| 61 | Deep venous thrombosis (HP:0002625) | 2.07226533 |
| 62 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.07000711 |
| 63 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.07000711 |
| 64 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.07000711 |
| 65 | Fat malabsorption (HP:0002630) | 2.05612735 |
| 66 | Subacute progressive viral hepatitis (HP:0006572) | 2.04787013 |
| 67 | Hypoplastic ischia (HP:0003175) | 2.04584089 |
| 68 | Irregular vertebral endplates (HP:0003301) | 2.03400025 |
| 69 | Entropion (HP:0000621) | 2.03262364 |
| 70 | Breast carcinoma (HP:0003002) | 2.02827287 |
| 71 | Cutaneous melanoma (HP:0012056) | 2.02177930 |
| 72 | Nonimmune hydrops fetalis (HP:0001790) | 2.01740514 |
| 73 | Vertebral compression fractures (HP:0002953) | 2.01583272 |
| 74 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.01274559 |
| 75 | Osteolytic defects of the hand bones (HP:0009699) | 2.00996230 |
| 76 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.00996230 |
| 77 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.00886829 |
| 78 | Steatorrhea (HP:0002570) | 2.00353030 |
| 79 | Hypobetalipoproteinemia (HP:0003563) | 2.00346797 |
| 80 | Abnormality of the umbilical cord (HP:0010881) | 2.00044090 |
| 81 | Flat capital femoral epiphysis (HP:0003370) | 1.98457270 |
| 82 | Upper limb muscle weakness (HP:0003484) | 1.98281950 |
| 83 | Thin bony cortex (HP:0002753) | 1.97409368 |
| 84 | Hepatocellular carcinoma (HP:0001402) | 1.97065625 |
| 85 | Small epiphyses (HP:0010585) | 1.95482397 |
| 86 | Abnormality of proline metabolism (HP:0010907) | 1.95438381 |
| 87 | Hydroxyprolinuria (HP:0003080) | 1.95438381 |
| 88 | Embryonal renal neoplasm (HP:0011794) | 1.93741553 |
| 89 | Abnormality of the ischium (HP:0003174) | 1.93625029 |
| 90 | Blue sclerae (HP:0000592) | 1.93570752 |
| 91 | Ependymoma (HP:0002888) | 1.93424769 |
| 92 | Nephroblastoma (Wilms tumor) (HP:0002667) | 1.92785777 |
| 93 | Pelvic girdle muscle weakness (HP:0003749) | 1.92355346 |
| 94 | Osteoarthritis (HP:0002758) | 1.92021972 |
| 95 | Biconcave vertebral bodies (HP:0004586) | 1.91383653 |
| 96 | Neoplasm of the adrenal gland (HP:0100631) | 1.90526624 |
| 97 | Curly hair (HP:0002212) | 1.90355535 |
| 98 | Abnormalities of placenta or umbilical cord (HP:0001194) | 1.90108694 |
| 99 | Spondylolisthesis (HP:0003302) | 1.89542910 |
| 100 | Soft skin (HP:0000977) | 1.89336813 |
| 101 | Exostoses (HP:0100777) | 1.88858022 |
| 102 | Abnormal delivery (HP:0001787) | 1.88628833 |
| 103 | Xanthomatosis (HP:0000991) | 1.88420265 |
| 104 | Prominent metopic ridge (HP:0005487) | 1.87803720 |
| 105 | Orthostatic hypotension (HP:0001278) | 1.87765881 |
| 106 | Bifid tongue (HP:0010297) | 1.87448585 |
| 107 | Skin nodule (HP:0200036) | 1.87426278 |
| 108 | Abnormality of dentin (HP:0010299) | 1.87061840 |
| 109 | Enlarged kidneys (HP:0000105) | 1.86719201 |
| 110 | Elevated alkaline phosphatase (HP:0003155) | 1.85727081 |
| 111 | Dysostosis multiplex (HP:0000943) | 1.85492186 |
| 112 | Atrophic scars (HP:0001075) | 1.85153894 |
| 113 | Ankle contracture (HP:0006466) | 1.85104731 |
| 114 | Neonatal short-limb short stature (HP:0008921) | 1.85092338 |
| 115 | Duodenal stenosis (HP:0100867) | 1.84501627 |
| 116 | Small intestinal stenosis (HP:0012848) | 1.84501627 |
| 117 | Disproportionate short-trunk short stature (HP:0003521) | 1.84326620 |
| 118 | Missing ribs (HP:0000921) | 1.83999525 |
| 119 | Asymmetry of the thorax (HP:0001555) | 1.83164951 |
| 120 | Intestinal atresia (HP:0011100) | 1.82493092 |
| 121 | Wormian bones (HP:0002645) | 1.82377814 |
| 122 | 11 pairs of ribs (HP:0000878) | 1.81968112 |
| 123 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.81096314 |
| 124 | Aneurysm (HP:0002617) | 1.80777335 |
| 125 | Meckel diverticulum (HP:0002245) | 1.80283504 |
| 126 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.80162950 |
| 127 | Cardiovascular calcification (HP:0011915) | 1.79794082 |
| 128 | Papillary thyroid carcinoma (HP:0002895) | 1.79743585 |
| 129 | Peritonitis (HP:0002586) | 1.79702068 |
| 130 | Insulin resistance (HP:0000855) | 1.79545740 |
| 131 | Mesomelia (HP:0003027) | 1.79233487 |
| 132 | Gonadotropin excess (HP:0000837) | 1.78580404 |
| 133 | Late onset (HP:0003584) | 1.78520827 |
| 134 | Abnormal biliary tract morphology (HP:0012440) | 1.77670866 |
| 135 | Flat acetabular roof (HP:0003180) | 1.77619712 |
| 136 | Secondary amenorrhea (HP:0000869) | 1.77585449 |
| 137 | Delayed gross motor development (HP:0002194) | 1.76550176 |
| 138 | Irregular epiphyses (HP:0010582) | 1.76142822 |
| 139 | Ketosis (HP:0001946) | 1.75063345 |
| 140 | Abnormality of the vertebral endplates (HP:0005106) | 1.73993486 |
| 141 | Blepharitis (HP:0000498) | 1.73294264 |
| 142 | Abnormal lung lobation (HP:0002101) | 1.72380295 |
| 143 | Abnormality of the duodenum (HP:0002246) | 1.72292547 |
| 144 | Abnormality of the metopic suture (HP:0005556) | 1.72249936 |
| 145 | Abnormal cartilage morphology (HP:0002763) | 1.71963742 |
| 146 | Abnormality of the acetabulum (HP:0003170) | 1.71827659 |
| 147 | Osteomalacia (HP:0002749) | 1.71456591 |
| 148 | Hypoalphalipoproteinemia (HP:0003233) | 1.71373840 |
| 149 | Cortical dysplasia (HP:0002539) | 1.71202477 |
| 150 | Abnormality of the ileum (HP:0001549) | 1.70726444 |
| 151 | Metaphyseal irregularity (HP:0003025) | 1.70497704 |
| 152 | Severe short stature (HP:0003510) | 1.70218360 |
| 153 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.69641227 |
| 154 | Relative macrocephaly (HP:0004482) | 1.69434326 |
| 155 | Ovoid vertebral bodies (HP:0003300) | 1.68984580 |
| 156 | Femoral bowing (HP:0002980) | 1.68720878 |
| 157 | Hypoplasia of the odontoid process (HP:0003311) | 1.68586088 |
| 158 | Vacuolated lymphocytes (HP:0001922) | 1.67705378 |
| 159 | Abnormality of the anterior horn cell (HP:0006802) | 1.67573492 |
| 160 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.67229631 |
| 161 | Abnormality of the preputium (HP:0100587) | 1.67020969 |
| 162 | Abnormal protein glycosylation (HP:0012346) | 1.66537198 |
| 163 | Abnormal glycosylation (HP:0012345) | 1.66537198 |
| 164 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.66537198 |
| 165 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.66537198 |
| 166 | Increased nuchal translucency (HP:0010880) | 1.66495250 |
| 167 | Short nail (HP:0001799) | 1.66442450 |
| 168 | Abnormal auditory evoked potentials (HP:0006958) | 1.65416125 |
| 169 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 1.64416032 |
| 170 | Proximal tubulopathy (HP:0000114) | 1.62517950 |
| 171 | Rhabdomyosarcoma (HP:0002859) | 1.61568853 |
| 172 | Abnormality of carpal bone ossification (HP:0006257) | 1.60661934 |
| 173 | Ovarian neoplasm (HP:0100615) | 1.60250172 |
| 174 | Pulmonic stenosis (HP:0001642) | 1.60068856 |
| 175 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 1.58207587 |
| 176 | Degeneration of anterior horn cells (HP:0002398) | 1.57816777 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 4.77228584 |
| 2 | PASK | 3.37331669 |
| 3 | INSRR | 3.22614236 |
| 4 | TRIM28 | 3.09197052 |
| 5 | TSSK6 | 2.93944350 |
| 6 | NEK1 | 2.83321282 |
| 7 | TAOK3 | 2.70249709 |
| 8 | ERN1 | 2.67356515 |
| 9 | FLT3 | 2.49760718 |
| 10 | LATS1 | 2.45922197 |
| 11 | WEE1 | 2.25763468 |
| 12 | BUB1 | 2.21578991 |
| 13 | MAP3K12 | 2.19535722 |
| 14 | PDK2 | 2.07156159 |
| 15 | TTK | 2.06732839 |
| 16 | ERBB3 | 2.03811356 |
| 17 | EPHA3 | 1.98894807 |
| 18 | MAP3K3 | 1.98758264 |
| 19 | PDGFRA | 1.98427492 |
| 20 | TRIB3 | 1.87997120 |
| 21 | MAP3K2 | 1.87274673 |
| 22 | NEK9 | 1.87153193 |
| 23 | PTK6 | 1.82937063 |
| 24 | SIK1 | 1.80859975 |
| 25 | SRPK1 | 1.79578142 |
| 26 | PLK2 | 1.66459482 |
| 27 | JAK3 | 1.63818338 |
| 28 | NUAK1 | 1.63239759 |
| 29 | PKN2 | 1.60580936 |
| 30 | BRSK2 | 1.59014348 |
| 31 | FGFR4 | 1.58659340 |
| 32 | MET | 1.58065669 |
| 33 | SIK3 | 1.47913132 |
| 34 | MAP3K14 | 1.46203132 |
| 35 | PNCK | 1.45628954 |
| 36 | SCYL2 | 1.40474076 |
| 37 | PLK4 | 1.36443776 |
| 38 | STK3 | 1.33100250 |
| 39 | TAF1 | 1.32148691 |
| 40 | TGFBR1 | 1.26124064 |
| 41 | STK38L | 1.26087413 |
| 42 | TRPM7 | 1.25378201 |
| 43 | TESK1 | 1.24851918 |
| 44 | DDR2 | 1.22997533 |
| 45 | EPHA2 | 1.22166320 |
| 46 | MKNK2 | 1.20486690 |
| 47 | PTK2 | 1.19119437 |
| 48 | MKNK1 | 1.17128113 |
| 49 | AKT3 | 1.15684180 |
| 50 | EIF2AK3 | 1.14333028 |
| 51 | JAK1 | 1.13060651 |
| 52 | FGFR3 | 1.12869355 |
| 53 | RPS6KA4 | 1.12818902 |
| 54 | PIK3CG | 1.11506483 |
| 55 | MYLK | 1.10610182 |
| 56 | EIF2AK2 | 1.06003793 |
| 57 | CHUK | 1.05089831 |
| 58 | STK10 | 1.01756217 |
| 59 | MAP4K2 | 0.95985385 |
| 60 | KSR1 | 0.94091901 |
| 61 | BRD4 | 0.92707181 |
| 62 | MAPK15 | 0.92250547 |
| 63 | STK39 | 0.91956926 |
| 64 | TYK2 | 0.89369107 |
| 65 | FER | 0.88646812 |
| 66 | HIPK2 | 0.88326010 |
| 67 | BCKDK | 0.87819657 |
| 68 | PLK1 | 0.87466544 |
| 69 | PDGFRB | 0.85901515 |
| 70 | RIPK1 | 0.84294768 |
| 71 | MST4 | 0.81957112 |
| 72 | BMPR2 | 0.78381731 |
| 73 | ZAP70 | 0.78108481 |
| 74 | LRRK2 | 0.72867000 |
| 75 | ACVR1B | 0.71222550 |
| 76 | PIM2 | 0.70469456 |
| 77 | TGFBR2 | 0.69512394 |
| 78 | CDK6 | 0.69499233 |
| 79 | CDK12 | 0.69431350 |
| 80 | EPHB1 | 0.68949579 |
| 81 | RPS6KB1 | 0.67764731 |
| 82 | IRAK3 | 0.66805360 |
| 83 | PRKD3 | 0.66789204 |
| 84 | ERBB4 | 0.66686342 |
| 85 | TNIK | 0.66584939 |
| 86 | MST1R | 0.65221928 |
| 87 | PIK3CA | 0.65058416 |
| 88 | STK24 | 0.64753056 |
| 89 | YES1 | 0.64461478 |
| 90 | MELK | 0.64240719 |
| 91 | TBK1 | 0.64143416 |
| 92 | CCNB1 | 0.62206161 |
| 93 | NLK | 0.60300562 |
| 94 | IRAK4 | 0.58770125 |
| 95 | JAK2 | 0.58549531 |
| 96 | IGF1R | 0.58536882 |
| 97 | PLK3 | 0.57998508 |
| 98 | PRKCE | 0.57785292 |
| 99 | ITK | 0.57055918 |
| 100 | ATM | 0.56558873 |
| 101 | FGFR1 | 0.56400304 |
| 102 | CDC42BPA | 0.55809501 |
| 103 | CSNK1G1 | 0.54455698 |
| 104 | AURKB | 0.54414403 |
| 105 | PAK2 | 0.53257995 |
| 106 | BCR | 0.53101046 |
| 107 | MTOR | 0.52916782 |
| 108 | WNK3 | 0.52832327 |
| 109 | CHEK1 | 0.51267284 |
| 110 | PRKCH | 0.50889594 |
| 111 | BRSK1 | 0.50266143 |
| 112 | IRAK1 | 0.49973351 |
| 113 | TTN | 0.49025872 |
| 114 | PAK3 | 0.48846463 |
| 115 | CLK1 | 0.48338926 |
| 116 | WNK4 | 0.47672879 |
| 117 | PAK4 | 0.46501203 |
| 118 | LMTK2 | 0.46416643 |
| 119 | TIE1 | 0.45612024 |
| 120 | NEK2 | 0.45397275 |
| 121 | DYRK1B | 0.44359138 |
| 122 | NEK6 | 0.44262709 |
| 123 | PBK | 0.44221475 |
| 124 | PRKG2 | 0.42157627 |
| 125 | MAP3K4 | 0.41645416 |
| 126 | RPS6KB2 | 0.41609993 |
| 127 | PRKCI | 0.41554763 |
| 128 | ATR | 0.40882130 |
| 129 | FGFR2 | 0.40520112 |
| 130 | GSK3A | 0.39766164 |
| 131 | BRAF | 0.38666963 |
| 132 | BMPR1B | 0.38307453 |
| 133 | ZAK | 0.37782475 |
| 134 | LIMK1 | 0.37709672 |
| 135 | EIF2AK1 | 0.37186302 |
| 136 | CSNK1A1L | 0.36907214 |
| 137 | CDC7 | 0.36307707 |
| 138 | CDK9 | 0.35433572 |
| 139 | INSR | 0.35074129 |
| 140 | IKBKB | 0.34700948 |
| 141 | CDK7 | 0.34539243 |
| 142 | CHEK2 | 0.34480713 |
| 143 | CAMK1D | 0.32594202 |
| 144 | CDK8 | 0.32501614 |
| 145 | EPHB2 | 0.30139917 |
| 146 | STK4 | 0.28678934 |
| 147 | CSNK1G3 | 0.28270257 |
| 148 | MAP3K8 | 0.25576243 |
| 149 | LATS2 | 0.25366520 |
| 150 | RAF1 | 0.24648330 |
| 151 | ROCK1 | 0.24529936 |
| 152 | EGFR | 0.23971195 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 5.33541985 |
| 2 | Protein export_Homo sapiens_hsa03060 | 4.65400008 |
| 3 | Sulfur metabolism_Homo sapiens_hsa00920 | 3.56536204 |
| 4 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 3.15963941 |
| 5 | Proteasome_Homo sapiens_hsa03050 | 2.77039504 |
| 6 | Selenocompound metabolism_Homo sapiens_hsa00450 | 2.17234613 |
| 7 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.12235571 |
| 8 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.10961087 |
| 9 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 2.07644561 |
| 10 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.90690799 |
| 11 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.81551355 |
| 12 | Basal transcription factors_Homo sapiens_hsa03022 | 1.80247273 |
| 13 | RNA transport_Homo sapiens_hsa03013 | 1.72758670 |
| 14 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.66550332 |
| 15 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.64821194 |
| 16 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.61166122 |
| 17 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.56691516 |
| 18 | Mismatch repair_Homo sapiens_hsa03430 | 1.55650446 |
| 19 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.51890844 |
| 20 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.51230863 |
| 21 | Cell cycle_Homo sapiens_hsa04110 | 1.50835235 |
| 22 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.50610833 |
| 23 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.49099065 |
| 24 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.47452127 |
| 25 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.46327339 |
| 26 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.45285200 |
| 27 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.44062496 |
| 28 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.42957015 |
| 29 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.42047272 |
| 30 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.40388080 |
| 31 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.37912609 |
| 32 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.37783584 |
| 33 | Homologous recombination_Homo sapiens_hsa03440 | 1.37302744 |
| 34 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.34305753 |
| 35 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.34181160 |
| 36 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.30590058 |
| 37 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 1.28587755 |
| 38 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.26811443 |
| 39 | Carbon metabolism_Homo sapiens_hsa01200 | 1.24177658 |
| 40 | Legionellosis_Homo sapiens_hsa05134 | 1.20333380 |
| 41 | RNA degradation_Homo sapiens_hsa03018 | 1.20090355 |
| 42 | Galactose metabolism_Homo sapiens_hsa00052 | 1.15733841 |
| 43 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.15320715 |
| 44 | Lysosome_Homo sapiens_hsa04142 | 1.13647377 |
| 45 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.13259553 |
| 46 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.11177677 |
| 47 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.07161959 |
| 48 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.02892033 |
| 49 | Other glycan degradation_Homo sapiens_hsa00511 | 0.99700536 |
| 50 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.99651638 |
| 51 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.98990672 |
| 52 | Histidine metabolism_Homo sapiens_hsa00340 | 0.98708834 |
| 53 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.98546448 |
| 54 | Focal adhesion_Homo sapiens_hsa04510 | 0.96799282 |
| 55 | Adherens junction_Homo sapiens_hsa04520 | 0.96634442 |
| 56 | Peroxisome_Homo sapiens_hsa04146 | 0.94372082 |
| 57 | Insulin resistance_Homo sapiens_hsa04931 | 0.94355528 |
| 58 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.92962247 |
| 59 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.91502373 |
| 60 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.89541575 |
| 61 | Lysine degradation_Homo sapiens_hsa00310 | 0.89287164 |
| 62 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.84049313 |
| 63 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.83928976 |
| 64 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.80913925 |
| 65 | DNA replication_Homo sapiens_hsa03030 | 0.80376277 |
| 66 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.80361128 |
| 67 | Prostate cancer_Homo sapiens_hsa05215 | 0.79759427 |
| 68 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.79569767 |
| 69 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.76785310 |
| 70 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.74296663 |
| 71 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.73472933 |
| 72 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.72243712 |
| 73 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.71506224 |
| 74 | Spliceosome_Homo sapiens_hsa03040 | 0.69974851 |
| 75 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.68273964 |
| 76 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.68172023 |
| 77 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.67977182 |
| 78 | ABC transporters_Homo sapiens_hsa02010 | 0.67907902 |
| 79 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.66970754 |
| 80 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.65814411 |
| 81 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.65344147 |
| 82 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.64511392 |
| 83 | Thyroid cancer_Homo sapiens_hsa05216 | 0.63831569 |
| 84 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.62592239 |
| 85 | Bladder cancer_Homo sapiens_hsa05219 | 0.62198767 |
| 86 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.61546050 |
| 87 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.61009438 |
| 88 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.60148800 |
| 89 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.59910188 |
| 90 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.59615633 |
| 91 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.59215956 |
| 92 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.58513350 |
| 93 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.57375212 |
| 94 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.57030683 |
| 95 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.56700109 |
| 96 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.56582432 |
| 97 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.55614920 |
| 98 | Amoebiasis_Homo sapiens_hsa05146 | 0.55213240 |
| 99 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.54206390 |
| 100 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.53786002 |
| 101 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.53564958 |
| 102 | Circadian rhythm_Homo sapiens_hsa04710 | 0.53394997 |
| 103 | Tight junction_Homo sapiens_hsa04530 | 0.53119486 |
| 104 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.50954574 |
| 105 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.50816932 |
| 106 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.50193436 |
| 107 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.49369932 |
| 108 | Prion diseases_Homo sapiens_hsa05020 | 0.49346969 |
| 109 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.49082810 |
| 110 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.48570085 |
| 111 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.48308637 |
| 112 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.48037314 |
| 113 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.47218425 |
| 114 | Shigellosis_Homo sapiens_hsa05131 | 0.46982860 |
| 115 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.46683551 |
| 116 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.46501240 |
| 117 | Metabolic pathways_Homo sapiens_hsa01100 | 0.45539746 |
| 118 | Leishmaniasis_Homo sapiens_hsa05140 | 0.45356412 |
| 119 | Phagosome_Homo sapiens_hsa04145 | 0.45187484 |
| 120 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.44089615 |
| 121 | Measles_Homo sapiens_hsa05162 | 0.42038563 |
| 122 | Hepatitis C_Homo sapiens_hsa05160 | 0.41688351 |
| 123 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.41432455 |
| 124 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.41373758 |
| 125 | Purine metabolism_Homo sapiens_hsa00230 | 0.40620631 |
| 126 | Base excision repair_Homo sapiens_hsa03410 | 0.40055609 |
| 127 | RNA polymerase_Homo sapiens_hsa03020 | 0.39828481 |
| 128 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.39512939 |
| 129 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.39224736 |
| 130 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.39100207 |
| 131 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.38230040 |
| 132 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.38229010 |
| 133 | Apoptosis_Homo sapiens_hsa04210 | 0.36414343 |
| 134 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.36084093 |
| 135 | Malaria_Homo sapiens_hsa05144 | 0.34996870 |
| 136 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.32896527 |
| 137 | Influenza A_Homo sapiens_hsa05164 | 0.32657600 |
| 138 | Retinol metabolism_Homo sapiens_hsa00830 | 0.32228286 |
| 139 | Hepatitis B_Homo sapiens_hsa05161 | 0.31397402 |
| 140 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.31196525 |
| 141 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.30102038 |

